The 9LLUC/Wistar rat glioma model is not suitable for immunotherapy☆

The availability of a well-characterized animal brain tumor model will play an important role in identifying treatments for human brain tumors. Wistar rats bearing 9L glioma cells can develop solid, well-circumcised tumors, and may be a useful animal model for the evaluation of various therapeutic approaches for gliosarcomas. In this study, the 9L/Wistar rat glioma model was produced by intracerebral implantation of 9LLUC glioma cells syngenic to Fischer 344 (F344) rats. Bioluminescence imaging showed that tumors progressively grew from day 7 to day 21 in 9LLUC/F344 rats, and tumor regression was found in some 9LLUC/Wistar rats. Hematoxylin-eosin staining verified that intracranial tumors were gliomas. Immunohistochemistry results demonstrated that no CD4- and CD8-positive cells were found in the syngeneic 9LLUC/F344 model. However, many infiltrating CD4- and CD8-positive cells were observed within the tumors of the 9LLUC/Wistar model. Our data suggests that compared with 9L/F344 rats, 9L glioma Wistar rats may not be suitable for evaluating brain glioma immunotherapies, even though the model induced an immune response and exhibited tumor regression.

[1]  Lin-Feng Yan,et al.  Effective inhibition of irradiation on human gliomas growth in vitro and in vivo after epidermal growth factor receptor silencing with RNA interference , 2011, Neuroreport.

[2]  A. Chakravarti,et al.  Recent advancements in multimodality treatment of gliomas. , 2011, Future oncology.

[3]  C. Hofstetter,et al.  Intra-Arterial Chemotherapy for Malignant Gliomas: A Critical Analysis , 2011, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[4]  G. Adema,et al.  TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas1 , 2008, The Journal of Immunology.

[5]  A. Gajjar,et al.  Chemotherapy for Malignant Brain Tumors of Childhood , 2008, Journal of child neurology.

[6]  P. Kelly,et al.  Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. , 2008, International journal of radiation oncology, biology, physics.

[7]  L. Buie,et al.  Bevacizumab: A Treatment Option for Recurrent Glioblastoma Multiforme , 2008, The Annals of pharmacotherapy.

[8]  Zeger Debyser,et al.  Noninvasive and Quantitative Monitoring of Adult Neuronal Stem Cell Migration in Mouse Brain Using Bioluminescence Imaging , 2008, Stem cells.

[9]  N. Tanriover,et al.  The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model , 2008, Neurological research.

[10]  杨丽平,et al.  Establishment of 9L/Wistar rats glioma models , 2007 .

[11]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[12]  L. Rakić,et al.  Characterization of 9L Glioma Model of the Wistar Rat , 2003, Journal of Neuro-Oncology.

[13]  J. Bruce,et al.  Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy. , 2000, Neurosurgery.

[14]  A. Kolozsvary,et al.  Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain. , 2000, International journal of radiation oncology, biology, physics.

[15]  B. Badie,et al.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.

[16]  M. Samii,et al.  Morphometrical Characterization of Two Glioma Models in the Brain of Immunocompetent and Immunodeficient Rats , 1999, Journal of Neuro-Oncology.

[17]  W. Sweet,et al.  Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. , 1971, Journal of neurosurgery.

[18]  Li Lu-si.  Constructing and applying of 9L~(luc) cells expressing firefly , 2007 .

[19]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas , 2004, Journal of Neuro-Oncology.

[20]  C. Woiciechowsky,et al.  Intratumoral infusion of interleukin-1beta and interferon-gamma induces tumor invasion with macrophages and lymphocytes in a rat glioma model. , 2004, Neuroscience letters.

[21]  D. Wedekind,et al.  Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. , 1999, Human gene therapy.